Natixis Agios Pharmaceuticals, Inc. Transaction History

Natixis

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$52.06 - $61.27 $24.2 Million - $28.5 Million	-465,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$44.23 - $57.5 $1.48 Million - $1.93 Million	33,500 Added 7.76%	465,000 $24 Million
Q4 2020 Feb 12, 2021	BUY	$33.21 - $46.54 $14.3 Million - $20.1 Million	431,500 New	431,500 $18.7 Million
Q1 2020 May 14, 2020	SELL	$31.52 - $53.81 $2.79 Million - $4.76 Million	-88,450 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $2.66 Million - $4.47 Million	88,450 New	88,450 $4.24 Million

234

58M

395K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.04B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.